Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

pembrolizumab 20 Bevacizumab 14 Carboplatin 12 Standard of Care 10 Nivolumab 9 Cyclophosphamide 9 Cetuximab 8 Pemetrexed 7 Exercise 7 Doxorubicin 7 durvalumab 6 atezolizumab 6 Temozolomide 6 Radiotherapy 6 Prednisone 6 Paclitaxel 6 Cisplatin 6 Blood Specimen Collection 6 abemaciclib 5 Fluorouracil 5 130-nm albumin-bound paclitaxel 5 olaparib 4 dostarlimab 4 Rituximab 4 Leucovorin 4 Gemcitabine 4 Fulvestrant 4 Docetaxel 4 Dexamethasone 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × anifrolumab × 30 days × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡